← Back to all clusters

Cluster 619

5 diseases · 4 shared-gene connections
5 Diseases
8 Unique genes
0.111 Avg. similarity score
Complex hereditary spastic paraplegia Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
B4GALNT1 2 / 5 Complex hereditary spastic paraplegia, Spastic paraplegia 26, autosomal recessive
GBA2 2 / 5 Complex hereditary spastic paraplegia, Spastic paraplegia 46, autosomal recessive
MAG 2 / 5 Complex hereditary spastic paraplegia, Spastic paraplegia 75, autosomal recessive
NT5C2 2 / 5 Complex hereditary spastic paraplegia, Spastic paraplegia 45, autosomal recessive
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Glycosphingolipid metabolism Reactome 2 / 46 65.3× 3.96e-4 5.58e-3 ✓ sig.
Sphingolipid metabolism KEGG 2 / 54 55.6× 5.46e-4 7.15e-3 ✓ sig.
Pyrimidine metabolism KEGG 2 / 58 51.8× 6.30e-4 7.99e-3 ✓ sig.
Nucleotide metabolism KEGG 2 / 85 35.3× 1.35e-3 1.42e-2 ✓ sig.
Signaling by plasma membrane FGFR1 fusions Reactome 1 / 3 500× 2.00e-3 1.90e-2 ✓ sig.
Abacavir metabolism Reactome 1 / 3 500× 2.00e-3 1.90e-2 ✓ sig.
Purine metabolism KEGG 2 / 128 23.5× 3.03e-3 2.56e-2 ✓ sig.
Phosphate bond hydrolysis by NTPDase proteins Reactome 1 / 8 188× 5.32e-3 3.80e-2 ✓ sig.
Axonal growth inhibition (RHOA activation) Reactome 1 / 9 167× 5.98e-3 4.10e-2 ✓ sig.
Purine catabolism Reactome 1 / 12 125× 7.97e-3 4.94e-2 ✓ sig.
Membrane binding and targetting of GAG proteins Reactome 1 / 14 107× 9.29e-3 5.43e-2
Glycosphingolipid biosynthesis - ganglio series KEGG 1 / 15 100× 9.95e-3 5.67e-2
Other glycan degradation KEGG 1 / 18 83.4× 1.19e-2 6.32e-2
Metabolic pathways KEGG 4 / 1,563 3.8× 1.29e-2 6.63e-2
Purinergic signaling in leishmaniasis infection Reactome 1 / 24 62.6× 1.59e-2 7.50e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
sphingolipid metabolic process GO:0006665 2 / 59 79.2× 2.71e-4 6.30e-3 ✓ sig.
GMP catabolic process to guanine GO:0006202 1 / 1 2,336× 4.28e-4 8.53e-3 ✓ sig.
purine ribonucleoside diphosphate catabolic process GO:0009181 1 / 2 1,168× 8.56e-4 1.33e-2 ✓ sig.
cholesterol metabolic process GO:0008203 2 / 107 43.7× 8.89e-4 1.37e-2 ✓ sig.
glucosylceramide catabolic process GO:0006680 1 / 3 779× 1.28e-3 1.67e-2 ✓ sig.
dGMP metabolic process GO:0046054 1 / 3 779× 1.28e-3 1.67e-2 ✓ sig.
ADP catabolic process GO:0046032 1 / 3 779× 1.28e-3 1.67e-2 ✓ sig.
steroid metabolic process GO:0008202 2 / 135 34.6× 1.41e-3 1.77e-2 ✓ sig.
IMP metabolic process GO:0046040 1 / 4 584× 1.71e-3 1.96e-2 ✓ sig.
negative regulation of defense response to virus by host GO:0050689 1 / 4 584× 1.71e-3 1.96e-2 ✓ sig.
nucleoside diphosphate catabolic process GO:0009134 1 / 4 584× 1.71e-3 1.96e-2 ✓ sig.
IMP catabolic process GO:0006204 1 / 5 467× 2.14e-3 2.19e-2 ✓ sig.
GMP catabolic process GO:0046038 1 / 5 467× 2.14e-3 2.19e-2 ✓ sig.
carbohydrate metabolic process GO:0005975 2 / 175 26.7× 2.35e-3 2.30e-2 ✓ sig.
central nervous system myelin formation GO:0032289 1 / 6 389× 2.57e-3 2.40e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Complex hereditary spastic paraplegia Spastic paraplegia 45, autosomal recessive 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Complex hereditary spastic paraplegia Spastic paraplegia 26, autosomal recessive 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Complex hereditary spastic paraplegia Spastic paraplegia 46, autosomal recessive 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Complex hereditary spastic paraplegia Spastic paraplegia 75, autosomal recessive 0.111 1 5.17e-4 9.13e-4 ✓ sig.